SCHEMBL438738

SCHEMBL438738

O=C1[CH]C(=O)NC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873513 0.69
SCHEMBL11457264 0.67
SCHEMBL123424 0.61
SCHEMBL5163707 0.59
SCHEMBL5161083 0.59
SCHEMBL10990 0.58
SCHEMBL33524954 0.58
SCHEMBL693917 0.58 GSK3B (1.00)
SCHEMBL7021498 0.58
SCHEMBL715867 0.58 GSK3B (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104744732-B Optical film, polarizing plate and liquid crystal display device using the same, and compound 富士胶片株式会社 2020-03-03 CN claimed
EP-1319659-A1 PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF Eisai Co., Ltd. (JP) 2003-06-18 EP claimed
US-20240025856-A1 1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AS INHIBITORS OF THE YAP/TAZ-TEAD ACTIVATION FOR TREATING CANCER CISTIM LEUVEN VZW (BE) 2024-01-25 US disclosed
CN-116783165-A 1,2,3, 4-tetrahydroquinoline derivatives as YAP/TAZ-TEAD activation inhibitors for the treatment of cancer 天主教鲁汶大学 2023-09-19 CN disclosed
EP-4222143-A1 1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AS INHIBITORS OF THE YAP/TAZ-TEAD ACTIVATION FOR TREATING CANCER Katholieke Universiteit Leuven (BE) 2023-08-09 EP disclosed
US-20230143643-A1 LOW DK COPPER CLAD LAMINATE COMPOSITIONS DESIGNER MOLECULES INC (US) 2023-05-11 US disclosed
US-20230095931-A1 UV-CURABLE RESIN COMPOSITIONS SUITABLE FOR REDISTRIBUTION LAYERS DESIGNER MOLECULES INC (US) 2023-03-30 US disclosed
EP-4097756-A2 UV-CURABLE RESIN COMPOSITIONS SUITABLE FOR REDISTRIBUTION LAYERS Designer Molecules, Inc. (US) 2022-12-07 EP disclosed
US-20220213267-A1 EXTREME HIGH TEMPERATURE STABLE ADHESIVES AND COATINGS DESIGNER MOLECULES, INC 2022-07-07 US disclosed
US-20220204696-A1 PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF DESIGNER MOLECULES, INC 2022-06-30 US disclosed
US-20220204766-A1 HIGH MOLECULAR WEIGHT FLEXIBLE CURABLE POLYIMIDES DESIGNER MOLECULES, INC 2022-06-30 US disclosed
WO-2005058808-A1 N-SUBSTITUTED-N-SULFONYLAMINOCYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-06-30 WO disclosed
WO-2005049582-A1 METHOD OF PREPARATION OF NOVEL NUCLEOSIDE ANALOGS AND USES AUSPEX PHARMACEUTICALS, INC. (US) 2005-06-02 WO disclosed
WO-2005044201-A2 PH SENSITIVE PRODRUGS OF 2,6-DIISOPROPYLPHENOL AUSPEX PHARMACEUTICALS, INC. (US) 2005-05-19 WO disclosed
US-6815183-B1 Plasmodium sp. chitinase THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2004-11-09 US disclosed
WO-2004064745-A2 METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES AUSPEX PHARMACEUTICALS, INC. (US) 2004-08-05 WO disclosed
EP-1319659-A1 PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF Eisai Co., Ltd. (JP) 2003-06-18 EP disclosed
WO-2000073488-A9 PLASMODIUM SP. CHITINASE UNIV TEXAS (US) 2002-04-18 WO disclosed
WO-2000073488-A1 PLASMODIUM SP. CHITINASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-12-07 WO disclosed
US-4189580-A FROM A CARBOXYLIC ACID AND CYANOGEN CHLORIDE OR BROMIDE BAYER AKTIENGESELLSCHAFT (DE) 1980-02-19 US disclosed